MedTrace Logo

Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease

NCT03770117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2021-01-19

No results posted yet for this study

Summary

The aim of this study is to assess whether prehabilitation supervised by an appropriate multimodality team improves indices of sarcopenia in patients scheduled to undergo pancreatoduodenectomy.

Conditions

Interventions

PROCEDURE

Prehabilitation

Participants who underwent Prehabilitation will have their CT scans analysed.

PROCEDURE

Standard Procedure

Patients who underwent a panctratoduodenectomy and did not receive any Prehabilitation will have their CT scans analysed and compared.

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Saurabh Jamdar · Manchester University NHS Foundation Trust

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-04
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770117 on ClinicalTrials.gov